ConductScience.org, home

Trial · NCT02865538

Participant flow15

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDPlacebo Comparator18
Overall StudySTARTED50 mg BAY342708015
Overall StudySTARTED100 mg BAY342708015
Overall StudySTARTED150 mg BAY342708015
Overall StudySTARTED300 mg of BAY342708013
Overall StudyCOMPLETEDPlacebo Comparator17
Overall StudyCOMPLETED50 mg BAY342708015
Overall StudyCOMPLETED100 mg BAY342708014
Overall StudyCOMPLETED150 mg BAY342708015
Overall StudyCOMPLETED300 mg of BAY342708013
Overall StudyNOT COMPLETEDPlacebo Comparator1
Overall StudyNOT COMPLETED50 mg BAY34270800
Overall StudyNOT COMPLETED100 mg BAY34270801
Overall StudyNOT COMPLETED150 mg BAY34270800
Overall StudyNOT COMPLETED300 mg of BAY34270800

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02865538/flow